KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Inventory Average (2016 - 2025)

Historic Inventory Average for NovoCure (NVCR) over the last 11 years, with Q3 2025 value amounting to $39.7 million.

  • NovoCure's Inventory Average fell 28.04% to $39.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.7 million, marking a year-over-year decrease of 28.04%. This contributed to the annual value of $36.6 million for FY2024, which is 845.58% up from last year.
  • Per NovoCure's latest filing, its Inventory Average stood at $39.7 million for Q3 2025, which was down 28.04% from $39.8 million recorded in Q2 2025.
  • NovoCure's Inventory Average's 5-year high stood at $41.4 million during Q2 2024, with a 5-year trough of $23.5 million in Q4 2021.
  • For the 5-year period, NovoCure's Inventory Average averaged around $33.0 million, with its median value being $32.4 million (2023).
  • In the last 5 years, NovoCure's Inventory Average crashed by 1267.51% in 2021 and then skyrocketed by 3345.32% in 2023.
  • Over the past 5 years, NovoCure's Inventory Average (Quarter) stood at $23.5 million in 2021, then grew by 19.33% to $28.1 million in 2022, then surged by 33.45% to $37.5 million in 2023, then fell by 1.04% to $37.1 million in 2024, then grew by 6.92% to $39.7 million in 2025.
  • Its Inventory Average stands at $39.7 million for Q3 2025, versus $39.8 million for Q2 2025 and $37.3 million for Q1 2025.